MESSAGE FOR THE CLINIC
Though some studies and reviews have suggested the efficacy of the oral
adsorbent AST-120 in delaying progression of CKD, this meta-analysis did
not find significant benefit over conventional treatment in terms of
clinically important outcomes. Hence, the use of AST-120 for the purpose
of delaying CKD progression does not appear to be evidence-based
practice as of this time.